Privia Health Group, Inc. Common Stock (PRVA) Financials
Key financial figures for Privia Health Group, Inc. Common Stock (Q3 2026).
Privia Health raised full-year 2026 guidance above the prior ranges after third-quarter revenue of $657.0M (+13.2%) and Adjusted EBITDA of $40.6M (+6.3%). Third-quarter revenue was $657.0M, up 13.2% from $580.4M a year earlier; gross profit was $134.7M (+9.9%) and operating income was $20.5M versus $14.4M. Net income attributable to Privia was $13.5M versus $6.9M, or $0.10 per diluted share versus $0.05. Non-GAAP adjusted net income per diluted share was $0.21 versus a recast $0.19 (27% statutory blended tax rate on adjustments). On the outlook: Full-year 2026 outlook raised at the Q3 release (11.5.26) versus the Q2 update (8.6.26): Attributed Lives 1,675,000 to 1,690,000 (from 1,625,000 to 1,650,000); Practice Collections $3,900M to $3,950M (from the high end of $3,650M to $3,750M); GAAP Revenue $2,500M to $2,550M (from the high end of $2,350M to $2,450M); Care Margin $535M to $540M (from mid to high end of $515M to $530M); Platform Contribution $280M to $285M (from mid to high end of $260M to $270M); Adjusted EBITDA $154M to $157M (from mid to high end of $145M to $155M); Implemented Providers now the high end of 5,900 to 6,000 (from no change). Management expects approximately 70% of Adjusted EBITDA to convert to free cash flow (the August release said 70% to 80%), including the American Choice Healthcare transaction and assuming the 2025 MSSP cash settlement occurs before year end. Guidance assumes no new business development activity. Figures are for Q3 2026, as Privia Health Group, Inc. reported them.
- Revenue
- $657M
- Net Income
- $13M
- EPS
- $0.11
- Total Assets
- $1.6B
- Operating Cash Flow
- $29M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q3 FY2026 | $657M | $13M | $0.10 | 3.13% | $29M |
| Q2 FY2026 | $633M | $9M | $0.07 | 1.86% | $1M |
| Q1 FY2026 | $604M | $3M | $0.02 | 1.23% | -$49M |
| Q4 FY2025 | $541M | $9M | $0.07 | 2.08% | $128M |
| Q3 FY2025 | $580M | $7M | $0.05 | 2.48% | $51M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $2.1B | $23M | $0.18 | 1.61% | $162M |
| FY2024 | $1.7B | $14M | $0.11 | 0.98% | $104M |
| FY2023 | $1.7B | $23M | $0.19 | 1.25% | $81M |
Frequently asked questions
What was Privia Health Group, Inc.'s revenue last quarter?
Privia Health Group, Inc. reported revenue of $657.0 million for Q3 FY2026, up 13.2% from the same period a year earlier.
Is Privia Health Group, Inc. profitable?
Yes. Privia Health Group, Inc. reported net income of $13.5 million for Q3 FY2026, a net margin of 2.05% on revenue.
How has Privia Health Group, Inc.'s margin trended?
Operating margin was 3.13% in Q3 FY2026, compared with 2.48% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Privia Health Group, Inc. generate?
Privia Health Group, Inc. generated free cash flow of $28.9 million in Q3 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Privia Health Group, Inc. Common Stock on SentiSense, with up to forty quarters and twenty fiscal years of history.